, 15:1 | Cite as

Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards

  • Richard D. BegerEmail author
Short Communication


Up to now, quality assurance (QA) and quality control (QC) in metabolomics are procedures that most labs did using their own in-house developed procedures and rules since there was no consensus or minimum requirement. Now there is a lot of enthusiasm for developing standardization of QA and QC procedures.


Quality control Metabolomics Biomarkers Harmonizing QC standards 


Compliance with ethical standards

Conflict of interest

The author declares that does not have any conflicts of interest.

Research involving human and animal participants

This manuscript does not contain any studies with human participants or animals that performed by the author.


  1. Bearden, D. W., Beger, R. D., Broadhurst, D., Dunn, W., Edison, A., Guillou, C., et al. (2014). The New Data Quality Task Group (DQTG): Ensuring high quality data today and in the future. Metabolomics, 10(4), 539.CrossRefGoogle Scholar
  2. Beger, R. D., Dunn, W. B., Bandukwala, A., Bethan, B., Broadhurst, D., Clish, C., et al. (2018). Think tank on quality assurance and quality control in untargeted metabolomics studies. Metabolomics. Scholar
  3. Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., et al. (2016). Metabolomics enables precision medicine: “A white paper, community perspective. Metabolomics, 12, 149. Scholar
  4. Broadhurst, D., Goodacre, R., Reinke, S. N., Kuligowski, J., Wilson, I. D., Lewis, M. R., et al. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14, 72. Scholar
  5. Clayton, T. A., Baker, D., Lindon, J. C., Everrett, J. R., & Nicholson, J. K. (2009). Pharmacometabolomics identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14728–14733.CrossRefGoogle Scholar
  6. Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIn- tyre, S., Anderson, N., et al. (2011). Procedures for large-scale metabolic profile of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6(7), 1060–1083.CrossRefGoogle Scholar
  7. Dunn, W. B., Broadhurst, D. I., Edison, A., Guillou, C., Viant, M. R., Bearden, D. W., et al. (2017). Quality assurance and quality control processes: Summary of a metabolomics community questionnaire. Metabolomics, 13(5), 50.CrossRefGoogle Scholar
  8. Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., et al. (2007). The metabolomics standards initiative (MSI). Metabolomics, 3, 175–178.CrossRefGoogle Scholar
  9. Kaddurah-Daouk, R., Weinshilboum, R. M., & Pharmacometabolomics Research Network. (2014). Pharma-cometabolomics: Implications for clinical pharmacology and systems pharmacology. Clinical Pharmacology and Therapeutics, 95(2), 154–167.CrossRefGoogle Scholar
  10. Lewis, M. R., Pearce, J. T., Spagou, K., Green, M., Dona, A. C., Yuen, A. H., et al. (2016). Development and application of ultra-performance liquid chromatorgraphy-TOF MS for precision large scale urinary metabolic phenotyping. Analytical Chemistry, 88(18), 9004–9013.CrossRefGoogle Scholar
  11. Sangster, T., Major, H., Plumb, R., Wilson, A. J., & Wilson, I. D. (2006). A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst, 131(10), 1075–1078.CrossRefGoogle Scholar
  12. Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., et al. (2006). The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnology, 24(9), 1151–1161.CrossRefGoogle Scholar
  13. Shi, L., Perkins, R. G., Fang, H., & Tong, W. (2008). Reproducible and reliable microarray results through quality control: Good laboratory proficiency and appropriate data analysis practices are essential. Current Opinion in Biotechnology, 19(1), 10–18.CrossRefGoogle Scholar

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply  2018

Authors and Affiliations

  1. 1.Division of Systems Biology, National Center for Toxicological ResearchUnited States Food and Drug AdministrationJeffersonUSA

Personalised recommendations